About: A cluster-randomised controlled trial to test the efficacy of facemasks in preventing respiratory viral infection among Hajj pilgrims

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A cluster-randomised controlled trial to test the efficacy of facemasks in preventing respiratory viral infection among Hajj pilgrims Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	A cluster-randomised controlled trial to test the efficacy of facemasks in preventing respiratory viral infection among Hajj pilgrims
Creator	Rashid, Harunor Barasheed, Osamah Booy, Robert El Bashir, Haitham Haworth, Elizabeth Heron, Leon Nguyen-Van-Tam, Jonathan Ridda, Iman Wang, Mandy Memish, Ziad Holmes, Edward Dwyer, Dominic
source	Elsevier; Medline; PMC
abstract	BACKGROUND: Cost-effective interventions are needed to control the transmission of viral respiratory tract infections (RTIs) in mass gatherings. Facemasks are a promising preventive measure, however, previous studies on the efficacy of facemasks have been inconclusive. This study proposes a large-scale facemask trial during the Hajj pilgrimage in Saudi Arabia and presents this protocol to illustrate its feasibility and to promote both collaboration with other research groups and additional relevant studies. METHODS/DESIGN: A cluster-randomised controlled trial is being conducted to test the efficacy of standard facemasks in preventing symptomatic and proven viral RTIs among pilgrims during the Hajj season in Mina, Mecca, Saudi Arabia. The trial will compare the ‘supervised use of facemasks’ versus ‘standard measures’ among pilgrims over several Hajj seasons. Cluster-randomisation will be done by accommodation tents with a 1:1 ratio. For the intervention tents, free facemasks will be provided to be worn consistently for 7 days. Data on flu-like symptoms and mask use will be recorded in diaries. Nasal samples will be collected from symptomatic recruits and tested for nucleic acid of respiratory viruses. Data obtained from questionnaires, diaries and laboratory tests will be analysed to examine whether mask use significantly reduces the frequency of laboratory-confirmed respiratory viral infection and syndromic RTI as primary outcomes. CONCLUSIONS: This trial will provide valuable evidence on the efficacy of standard facemask use in preventing viral respiratory tract infections at mass gatherings. This study is registered at the Australian New Zealand Clinical Trials Registry (ANZCTR), ACTRN: ACTRN12613001018707 (http://www.anzctr.org.au).
has issue date	2014-10-02(xsd:dateTime)
bibo:doi	10.1016/j.jegh.2014.08.002
bibo:pmid	25922328
has license	no-cc
sha1sum (hex)	e279f4afd8d1def9b69ae41e53746314cee28af1
schema:url	https://doi.org/10.1016/j.jegh.2014.08.002
resource representing a document's title	A cluster-randomised controlled trial to test the efficacy of facemasks in preventing respiratory viral infection among Hajj pilgrims
has PubMed Central identifier	PMC7103985
has PubMed identifier	25922328
schema:publication	J Epidemiol Glob Health
resource representing a document's body	covid:e279f4afd8d1def9b69ae41e53746314cee28af1#body_text
is schema:about of	named entity 'preventing' named entity 'RANDOMISED CONTROLLED TRIAL' named entity 'LARGE' named entity 'EFFICACY' named entity 'STUDY' named entity 'HAVE' named entity 'EFFECTIVE INTERVENTIONS' named entity 'PREVENTING' named entity 'INCONCLUSIVE' named entity 'CLUSTER' named entity 'EFFICACY' named entity 'TO TEST' named entity 'RESPIRATORY VIRAL INFECTION' named entity 'TO CONTROL' named entity 'TRANSMISSION' named entity 'MEASURE' named entity 'NEEDED' named entity 'PREVIOUS' named entity 'PREVENTIVE' named entity 'SCALE' named entity 'RESPIRATORY TRACT INFECTIONS' named entity 'STUDIES' named entity 'BACKGROUND' named entity 'HTTP' named entity 'VIRAL' named entity 'MASS' named entity 'COST' covid:arg/e279f4afd8d1def9b69ae41e53746314cee28af1 named entity 'viral' named entity 'gatherings' named entity 'transmission' named entity 'respiratory tract infections' named entity 'This' named entity 'efficacy' named entity 'randomised controlled trial' named entity 'Hajj' named entity 'MERS-CoV' named entity 'viral infection' named entity 'follow-up' named entity 'influenza vaccination' named entity 'Malaysia' named entity 'Saudi Arabia' named entity 'human metapneumovirus' named entity 'Westmead' named entity 'genomic sequencing' named entity 'public health' named entity 'viruses' named entity 'antipyretics' named entity 'Hajj' named entity 'flu-like symptoms' named entity 'Surgical Mask' named entity 'intention-to-treat analysis' named entity 'hand hygiene' named entity 'Hajj' named entity 'randomised trial' named entity 'crowded places' named entity 'viruses' named entity 'barcode' named entity 'Hajj' named entity 'Hajj' named entity 'Hajj' named entity 'influenza' named entity 'MERS CoV' named entity 'Westmead Hospital' named entity 'health education' named entity 'respiratory infection' named entity 'fever' named entity 'Qatar' named entity 'respiratory diseases' named entity 'Turkey'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software